Does the TLR1 rs4833095 variant change innate sensing of bacterial lipoproteins and infection risk?

The TLR1 rs4833095 polymorphism significantly alters the human innate immune response to bacterial pathogens by modifying how the body detects triacylated lipoproteins. This genetic variant is a critical determinant of both susceptibility to infection and the intensity of subsequent inflammatory diseases, such as Lyme arthritis.

Mechanistic explanations

The primary mechanism driving this association is a defect in receptor trafficking and localization.

• Receptor Trafficking: The rs4833095 polymorphism (often linked with the I602S variant) involves an amino acid substitution that disrupts a cytoplasmic motif necessary for transporting the TLR1 receptor to the cell surface.
• Surface Expression: This leads to the intracellular retention of TLR1, resulting in a marked reduction of functional TLR1/TLR2 heterodimers at the plasma membrane.
• Signaling Blunting: Because these heterodimers are the primary sensors for triacylated lipoproteins, their absence leads to significant hyporesponsiveness. This manifests as reduced NF-κB activation and lower production of pro-inflammatory cytokines like TNF-α and IL-6 when exposed to bacterial ligands.

Clinical evidence and susceptibility

The functional deficit caused by rs4833095 translates into divergent clinical outcomes depending on the pathogen involved.

• Lyme Disease (Borrelia): The polymorphism is strongly linked to the severity of Lyme arthritis. While lower signaling can sometimes reduce inflammation, specific genotypes (such as the 1805GG genotype) are associated with heightened Th1-like inflammatory responses, leading to elevated cytokine levels in joint fluid and a higher risk of antibiotic-refractory arthritis.
• Other Bacterial Infections: The variant significantly modulates risk for other infections. It is associated with increased susceptibility to pulmonary tuberculosis and leprosy due to impaired initial pathogen clearance. Conversely, the dampened signaling may offer a protective effect against conditions driven by hyper-inflammation, such as sepsis or H. pylori-induced gastritis.

Bottom line

The TLR1 rs4833095 variant reduces cell-surface TLR1/TLR2 signaling, which directly alters the host's ability to regulate inflammation and clear bacterial infections, significantly impacting the clinical course of Lyme disease and mycobacterial infections.